Sintilimab and Lenalidomide as a Treatment for CAEBV
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This study is a multi-center, prospective, randomized, controlled clinical study to evaluate
the effectiveness of a combination regimen of Sintilimab and lenalidomide in patients with
chronic active EBV infection.